Candel Therapeutics (CADL) Return on Equity [ROE] (2021 - 2026)
Candel Therapeutics' Return on Equity [ROE] came in at -73.71% for Q2 2026, down 30.96 percentage points from -42.74% a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Candel Therapeutics' Return on Equity [ROE] was -78.60%, up 8.35 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +48.47 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -86.95% in FY2024 (+41.75 pp), -128.70% in FY2023 (-65.74 pp), -62.96% in FY2022 (+64.11 pp) and -127.07% in FY2021.
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q4 2024.
- Year-over-year, Return on Equity [ROE] increased in three of the last four quarters, with an average year-over-year change of +117.53 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 353.92 percentage points), and the weakest in Q1 2024 (a drop of 320.19 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Candel Therapeutics | 711.71 Mn | 108.61 Mn | - | -54.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.25% |
| Mar 31, 2026 | -58.43% |
| Dec 31, 2025 | -70.38% |
| Sep 30, 2025 | -45.38% |
| Jun 30, 2025 | -42.74% |
| Mar 31, 2025 | -47.73% |
| Dec 31, 2024 | -134.62% |
| Mar 31, 2024 | -401.64% |
| Dec 31, 2023 | -217.55% |
| Sep 30, 2023 | -134.60% |
| Jun 30, 2023 | -102.90% |
| Mar 31, 2023 | -81.45% |
| Dec 31, 2022 | -70.53% |
| Sep 30, 2022 | -45.88% |
| Jun 30, 2022 | -53.05% |
| Mar 31, 2022 | -63.81% |
| Dec 31, 2021 | -57.13% |
| Sep 30, 2021 | -488.99% |
API Access
Candel Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();